[FG] Donath Marc

Aubry, Yoann, Dosch, Michel and Donath, Marc Y. (2024) ‘Cardiac evaluation in amiodarone-induced thyroid dysfunction with suspected cardiac ischemia?: a case report and review of the literature’, Journal of Medical Case Reports, 18(1). Available at: https://doi.org/10.1186/s13256-024-04552-w.

Hofwimmer, Kaisa et al. (2024) ‘IL-1β promotes adipogenesis by directly targeting adipocyte precursors’, Nature Communications , 15(1). Available at: https://doi.org/10.1038/s41467-024-51938-x.

Lazaridis, I.I. et al. (2024) ‘Family planning, reproductive health and pregnancy after bariatric surgery: a survey of bariatric healthcare professionals in Switzerland’, Swiss Medical Weekly, 154(12), pp. 1–10. Available at: https://doi.org/10.57187/s.3841.

Wälchli-Popovic, Milica et al. (2024) ‘Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial’, Frontiers in Endocrinology. 11.09.2024, 15. Available at: https://doi.org/10.3389/fendo.2024.1435698.

Burak, Mehmet Furkan et al. (2024) ‘Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023’, American Journal of Clinical Nutrition, 120(1), pp. 257–268. Available at: https://doi.org/10.1016/j.ajcnut.2024.04.029.

Bazile, Cassandra et al. (2024) ‘TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial’, Frontiers in Immunology, 15. Available at: https://doi.org/10.3389/fimmu.2024.1470677.

Steiger, Laura et al. (2023) ‘Protocol for isolation and spectral flow cytometry analysis of immune cells from the murine exocrine and endocrine pancreas’, STAR Protocols, 4(4), p. 102664. Available at: https://doi.org/10.1016/j.xpro.2023.102664.

Steiger, Laura et al. (2023) ‘Protocol for isolation and spectral flow cytometry analysis of immune cells from the murine exocrine and endocrine pancreas’, STAR Protocols, 4(4), p. 102664. Available at: https://doi.org/10.1016/j.xpro.2023.102664.

Bosch, A.J.T. et al. (2023) ‘Lung versus gut exposure to air pollution particles differentially affect metabolic health in mice’, Particle and Fibre Toxicology, 20(1). Available at: https://doi.org/10.1186/s12989-023-00518-w.

Quansah, Dan Yedu et al. (2023) ‘C-reactive protein during pregnancy and in the early postpartum predicts adverse metabolic health outcomes at 1 year postpartum in women with gestational diabetes’, Cardiovascular Diabetology, 22(1). Available at: https://doi.org/10.1186/s12933-023-02034-9.

Wirth, Fabian et al. (2023) ‘A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models’, Nature Communications, 14(1). Available at: https://doi.org/10.1038/s41467-023-41986-0.

Borisov, Angel N. et al. (2023) ‘Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS’, Journal of Clinical Endocrinology and Metabolism, 108(11), pp. 2940–2949. Available at: https://doi.org/10.1210/clinem/dgad249.

de Baat, A. et al. (2023) ‘Cystine/glutamate antiporter System xc- deficiency impairs insulin secretion in mice’, Diabetologia, 66(11), pp. 2062–2074. Available at: https://doi.org/10.1007/s00125-023-05993-6.

de Baat, Axel et al. (2023) ‘Cystine/glutamate antiporter System xc- deficiency impairs insulin secretion in mice’, Diabetologia, 66(11), pp. 2062–2074. Available at: https://doi.org/10.1007/s00125-023-05993-6.

de Baat, A. et al. (2023) ‘Cystine/Glutamate antiporter system xcdeficiency impairs macrophage glutathione metabolism and cytokine production’, PLoS ONE, 18(10 October). Available at: https://doi.org/10.1371/journal.pone.0291950.

de Baat, Axel et al. (2023) ‘Cystine/Glutamate antiporter system xcdeficiency impairs macrophage glutathione metabolism and cytokine production’, PLoS ONE, 18(10 October), p. e0291950. Available at: https://doi.org/10.1371/journal.pone.0291950.

Meier, Christian et al. (2023) ‘Biochemical Markers of Bone Fragility in Patients With Diabetes’, Journal of Clinical Endocrinology and Metabolism, 108(10), pp. e923–e936. Available at: https://doi.org/10.1210/clinem/dgad255.

Monnerat, Sophie et al. (2023) ‘An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD’, Journal of Clinical Endocrinology and Metabolism, 108(10), pp. e1027–e1033. Available at: https://doi.org/10.1210/clinem/dgad238.

Perakakis, N. et al. (2023) ‘Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases’, The Lancet Diabetes and Endocrinology, 11(9), pp. 675–693. Available at: https://doi.org/10.1016/S2213-8587(23)00154-7.

de Baat, Axel et al. (2023) ‘Physiological role of cytokines in the regulation of mammalian metabolism’, Trends in Immunology, 44(8), pp. 613–627. Available at: https://doi.org/10.1016/j.it.2023.06.002.

Ferreira, Antonio et al. (2023) ‘Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass’, Diabetes Technology and Therapeutics, 25(7), pp. 467–475. Available at: https://doi.org/10.1089/dia.2023.0036.

Ebrahimi F and Ludvigsson JF (2023) ‘Letter to the editor: Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort’, Hepatology. Wolters Kluwer Medknow Publications, 77(5). Available at: https://doi.org/10.1097/HEP.0000000000000273.

Vielhaber JA et al. (2023) ‘Severe Abdominal Pain After Bariatric Surgery: Think Twice—Think Porphyria!’, Obesity Surgery, 33(5). Available at: https://doi.org/10.1007/s11695-023-06555-w.

Ferrari, Serge and Meier, Christian (2023) ‘Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)’, Swiss Medical Weekly, 153(4). Available at: https://doi.org/10.57187/smw.2023.40075.

Komminoth, Mathis et al. (2023) ‘Glucocorticoid withdrawal and glucocorticoidinduced adrenal insufficiency: Study protocol of the randomized controlled «TOASST’ (Taper Or Abrupt Steroid STop) multicenter trial’, PLoS ONE, 18(4 April). Available at: https://doi.org/10.1371/journal.pone.0281585.

Lengsfeld, Sophia et al. (2023) ‘Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial’, eClinicalMedicine, 57, p. 101865. Available at: https://doi.org/10.1016/j.eclinm.2023.101865.

Jung, Ruedi et al. (2023) ‘Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit)’, International Journal of Cancer, 152(2), pp. 162–171. Available at: https://doi.org/10.1002/ijc.34234.

Daetwyler, Eveline et al. (2023) ‘Nivolumab-induced diabetes mellitus—a case report with literature review of the treatment options’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1248919.

Guha Ray, Preetam et al. (2023) ‘A versatile bioelectronic interface programmed for hormone sensing.’, Nature Communications, 14. Available at: https://doi.org/10.1038/s41467-023-39015-1.

Minder, Anna-Elisabeth et al. (2023) ‘Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria.’, Life, 13(4), p. 1066. Available at: https://doi.org/10.3390/life13041066.

Meier, Daniel T et al. (2022) ‘Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing’, Nature Communications, 13(1), p. 4761. Available at: https://doi.org/10.1038/s41467-022-32509-4.

Meier DT et al. (2022) ‘Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing’, Nature Communications, 13(1), p. 4761. Available at: https://doi.org/10.1038/s41467-022-32509-4.

R Charlier SH et al. (2022) ‘Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study’, Cardiovascular Diabetology, 21(1), p. 2. Available at: https://doi.org/10.1186/s12933-021-01432-1.

Hepprich, Matthias et al. (2022) ‘Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial’, eClinicalMedicine, 53. Available at: https://doi.org/10.1016/j.eclinm.2022.101649.

Donath MY (2022) ‘Type 1 diabetes: what is the role of autoimmunity in β cell death?’, Journal of Clinical Investigation, 132(20). Available at: https://doi.org/10.1172/JCI164460.

Wiedemann SJ et al. (2022) ‘The cephalic phase of insulin release is modulated by IL-1β’, Cell Metabolism, 34(7), pp. 991–1003.e6. Available at: https://doi.org/10.1016/j.cmet.2022.06.001.

Bischof E et al. (2022) ‘Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience’, Bone Reports, 16, p. 101160. Available at: https://doi.org/10.1016/j.bonr.2021.101160.

Koehler V.F. et al. (2022) ‘Medullary thyroid cancer with ectopic Cushing’s syndrome: A multicentre case series’, Clinical Endocrinology, 96(6), pp. 847–856. Available at: https://doi.org/10.1111/cen.14617.

Sewing L et al. (2022) ‘Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes’, Journal of Bone and Mineral Research, 37(5), pp. 837–847. Available at: https://doi.org/10.1002/jbmr.4517.

Hepprich, M. et al. (2022) Glucagon-like peptide-1 receptor PET/CT in patients with and without post gastric bypass hypoglycemia – a prospective, matched case-control study. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-1561857/v1.

Jehle‐kunz, Sigrid et al. (2022) ‘Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey’, Healthcare (Switzerland), 10(2). Available at: https://doi.org/10.3390/healthcare10020295.

Rohm TV et al. (2022) ‘Inflammation in obesity, diabetes, and related disorders’, Immunity, 55(1), pp. 31–55. Available at: https://doi.org/10.1016/j.immuni.2021.12.013.

Fawcett C et al. (2022) ‘Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration’, Acta Cytologica, 66(5), pp. 371–378. Available at: https://doi.org/10.1159/000522662.

Hoffmann, C. et al. (2022) ‘Liver, NAFLD and COVID-19’, Hormone and Metabolic Research [Preprint]. Available at: https://doi.org/10.1055/a-1834-9008.

Paccou J. et al. (2022) ‘Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)’, Bone, 154. Available at: https://doi.org/10.1016/j.bone.2021.116236.

Potasso L et al. (2022) ‘Effect of hyponatremia normalization on osteoblast function in patients with SIAD’, European Journal of Endocrinology, 186(1), pp. 1–8. Available at: https://doi.org/10.1530/EJE-21-0604.

Vavanikunnel, J. et al. (2022) ‘Determinants of low bone turnover in type 2 diabetes-the role of PTH’, Calcif Tissue Int, 111(6), pp. 587–596. Available at: https://doi.org/10.1007/s00223-022-01022-7.

Matthias Hepprich et al. (2022) ‘Glucagon-Like Peptide-1 Receptor Pet/Ct in Patients with and Without Post Gastric Bypass Hypoglycemia: A Prospective, Matched Case-Control Study’, J Gastrointest Dig Systems [Preprint]. 15-Jun-2022, (12). Available at: https://doi.org/10.4172/2161-069x.1000686.

Tynes M., Hepprich M. and Timper K. (2021) ‘Regular intake of energy drinks and multivitamin supplements is associated with elevated plasma vitamin B6 levels in post-bariatric patients’, Scientific Reports, 11(1). Available at: https://doi.org/10.1038/s41598-021-97205-7.

Böni-Schnetzler, Marianne et al. (2021) ‘IL-1beta promotes the age-associated decline of beta cell function’, iScience, 24(11). Available at: https://doi.org/10.1016/j.isci.2021.103250.

Zweck E., Hepprich M and Donath M.Y. (2021) ‘Predictors of Postprandial Hypoglycemia After Gastric Bypass Surgery: a Retrospective Case-Control Study’, Obesity Surgery, 31(6), pp. 2497–2502. Available at: https://doi.org/10.1007/s11695-021-05277-1.

Rohm TV et al. (2021) ‘Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation’, Frontiers in Immunology, 12, p. 668654. Available at: https://doi.org/10.3389/fimmu.2021.668654.

Schiavon M. et al. (2021) ‘Model-Based Assessment of C-Peptide Secretion and Kinetics in Post Gastric Bypass Individuals Experiencing Postprandial Hyperinsulinemic Hypoglycemia’, Frontiers in Endocrinology, 12. Available at: https://doi.org/10.3389/fendo.2021.611253.

Hepprich M et al. (2021) ‘Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study’, Diabetes Therapy, 12(3), pp. 943–954. Available at: https://doi.org/10.1007/s13300-021-01016-y.

Netea MG et al. (2021) ‘Author Correction: A guiding map for inflammation.’, 22(2). Available at: https://doi.org/10.1038/s41590-020-00846-5.

Hepprich, M., Donath, M.Y. and Hemkens, L.G. (2021) ‘Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-55915/v2.

Donath MY (2021) ‘Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?’, Cell Metabolism, 33(1), pp. 2–4. Available at: https://doi.org/10.1016/j.cmet.2020.11.015.

Charlier, Sarah et al. (2021) ‘Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study’, Journal of Clinical Endocrinology and Metabolism, 106(2), pp. 554–566. Available at: https://doi.org/10.1210/clinem/dgaa796.

Tsourdi E et al. (2021) ‘Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS’, Journal of Clinical Endocrinology and Metabolism, 106(1), pp. 264–281. Available at: https://doi.org/10.1210/clinem/dgaa756.

Winzeler B et al. (2021) ‘A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia’, Journal of Clinical Investigation, 131(20). Available at: https://doi.org/10.1172/JCI151800.

Wueest S. et al. (2021) ‘Il-6 receptor blockade increases circulating adiponectin levels in people with obesity: An explanatory analysis’, Metabolites, 11(2), pp. 1–7. Available at: https://doi.org/10.3390/metabo11020079.

Hepprich M, Donath MY and Hemkens L.G. (2020) ‘Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia’, BMC Medical Research Methodology, 20(1), p. 290. Available at: https://doi.org/10.1186/s12874-020-01171-z.

Wiedemann SJ et al. (2020) ‘Evidence for cephalic phase insulin release in humans: A systematic review and meta-analysis’, Appetite, 155, p. 104792. Available at: https://doi.org/10.1016/j.appet.2020.104792.

Dahlby T et al. (2020) ‘Enhancer of zeste homolog 2 (Ezh2) mediates glucolipotoxicity-induced apoptosis in β-cells’, International Journal of Molecular Sciences, 21(21), pp. 1–18. Available at: https://doi.org/10.3390/ijms21218016.

Rosenberg R et al. (2020) ‘[Adrenal tumors].’, Therapeutische Umschau. Revue therapeutique, 77(9), pp. 441–448. Available at: https://doi.org/10.1024/0040-5930/a001216.

Zürcher SJ et al. (2020) ‘High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit’, International Journal of Cancer, 147(7), pp. 1845–1854. Available at: https://doi.org/10.1002/ijc.32963.

Ferrari S et al. (2020) ‘2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)’, Swiss Medical Weekly, 150(3940), p. w20352. Available at: https://doi.org/10.4414/SMW.2020.20352.

Antwi K et al. (2020) ‘Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging’, Clinical Nuclear Medicine, 45(9), pp. E386–E392. Available at: https://doi.org/10.1097/RLU.0000000000003124.

Schneider R et al. (2020) ‘GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis’, Obesity Surgery, 30(9), pp. 3561–3569. Available at: https://doi.org/10.1007/s11695-020-04750-7.

Pepe J. et al. (2020) ‘Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF’, Journal of Clinical Endocrinology and Metabolism, 105(8), pp. 2487–2506. Available at: https://doi.org/10.1210/clinem/dgaa306.

Burmester GR et al. (2020) ‘Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial’, The Lancet, 396(10246), pp. 267–276. Available at: https://doi.org/10.1016/S0140-6736(20)30636-X.

Sarcevic J et al. (2020) ‘Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism’. Frontiers Media S.A., 11. Available at: https://doi.org/10.3389/fimmu.2020.01435.

Gerendas BS et al. (2020) ‘Ganglion cell layer thickening in well-controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?’, Acta Ophthalmologica, 98(3), pp. e292–e300. Available at: https://doi.org/10.1111/aos.14273.

Hepprich M et al. (2020) ‘Postprandial Hypoglycemia in Patients after Gastric Bypass Surgery Is Mediated by Glucose-Induced IL-1β’, Cell Metabolism, 31(4), pp. 699–709.e5. Available at: https://doi.org/10.1016/j.cmet.2020.02.013.

Brykczynska U et al. (2020) ‘Distinct Transcriptional Responses across Tissue-Resident Macrophages to Short-Term and Long-Term Metabolic Challenge’, Cell Reports, 30(5), pp. 1627–1643.e7. Available at: https://doi.org/10.1016/j.celrep.2020.01.005.

Ellingsgaard H et al. (2020) ‘GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study’, Diabetologia, 63(2), pp. 362–373. Available at: https://doi.org/10.1007/s00125-019-05045-y.

Müller F et al. (2020) ‘Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee’, Knee Surgery, Sports Traumatology, Arthroscopy, 28(2), pp. 408–417. Available at: https://doi.org/10.1007/s00167-019-05598-w.

Hepprich M et al. (2020) ‘Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging’. Hindawi Limited410 Park Avenue, 15th Floor, 287 pmbNew YorkNY 10022, 2020. Available at: https://doi.org/10.1155/2020/4510910.

Meienberg F (2020) ‘[The adrenal incidentaloma].’, Therapeutische Umschau. Revue therapeutique, 77(8), pp. 357–360. Available at: https://doi.org/10.1024/0040-5930/a001204.

Schulze, Friederike et al. (2020) ‘Inhibition of IL-1beta improves Glycaemia in a Mouse Model for Gestational Diabetes’, Scientific Reports, 10(1), p. 3035. Available at: https://doi.org/10.1038/s41598-020-59701-0.

Trinh B, Donath MY and Läubli H (2020) ‘Successful treatment of immune checkpoint inhibitor-induced diabetes with infliximab. Diabetes Care 2019;42:e153-e154’, 43(1). Available at: https://doi.org/10.2337/dci19-0058.

Donath MY, Dinarello CA and Mandrup-Poulsen T (2019) ‘Targeting innate immune mediators in type 1 and type 2 diabetes’, Nature Reviews Immunology, 19(12), pp. 734–746. Available at: https://doi.org/10.1038/s41577-019-0213-9.

Anastasilakis AD et al. (2019) ‘Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society’, Bone, 127, pp. 401–418. Available at: https://doi.org/10.1016/j.bone.2019.07.006.

Donath MY (2019) ‘Designer cytokine for the treatment of diabetes’, Nature Metabolism, 1(10), pp. 933–934. Available at: https://doi.org/10.1038/s42255-019-0130-z.

Trinh B, Donath MY and Läubli H (2019) ‘Successful treatment of immune checkpoint inhibitor-induced diabetes with infliximab’, 42(9). Available at: https://doi.org/10.2337/dc19-0908.

Biver E, Calmy A and Meier C (2019) ‘Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf’, 30(8). Available at: https://doi.org/10.1007/s00198-019-05025-3.

Böni-Schnetzler M and Meier DT (2019) ‘Islet inflammation in type 2 diabetes’, Seminars in Immunopathology, 41(4), pp. 501–513. Available at: https://doi.org/10.1007/s00281-019-00745-4.

Donath MY (2019) ‘Inflammation and type 2 diabetes: from basic science to treatment’, 41(4). Available at: https://doi.org/10.1007/s00281-019-00749-0.

Urwyler SA et al. (2019) ‘Cytokines and Cortisol – predictors of treatment response to corticosteroids in community-acquired pneumonia?’, Journal of Internal Medicine, 286(1), pp. 75–87. Available at: https://doi.org/10.1111/joim.12891.

Donath MY, Meier DT and Böni-Schnetzler M (2019) ‘Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease’, Endocrine Reviews, 40(4), pp. 1080–1091. Available at: https://doi.org/10.1210/er.2019-00002.

Biver E et al. (2019) ‘Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis’, Osteoporosis International, 30(5), pp. 1125–1135. Available at: https://doi.org/10.1007/s00198-018-4794-0.

Struja T et al. (2019) ‘Comparison of Five TSH-receptor antibody assays in Graves” disease: Results from an observational pilot study’, BMC Endocrine Disorders, 19(1), p. 38. Available at: https://doi.org/10.1186/s12902-019-0363-6.

Hepprich, Matthias et al. (2019) ‘Novel insights into postprandial hypoglycemia after gastric bypass: Empagliflozin as well as Anakinra reduce symptomatic episodes by lowered insulin secretion’. SPRINGER HEIDELBERG, 60.

Kaiser N et al. (2019) ‘Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry’, Molecular Genetics and Metabolism, 126(4), pp. 355–361. Available at: https://doi.org/10.1016/j.ymgme.2019.02.008.

Hatz K et al. (2019) ‘The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control’, Diabetes Research and Clinical Practice, 148, pp. 234–239. Available at: https://doi.org/10.1016/j.diabres.2019.01.016.

Zulewski H et al. (2019) ‘Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland’, Swiss medical weekly, 149, p. w14700. Available at: https://doi.org/10.4414/smw.2019.14700.

Blum, Claudine A. et al. (2019) ‘Cosyntropin testing does not predict response to glucocorticoids in community-acquired pneumonia in a randomized controlled trial’, Clinical endocrinology, 91(3), pp. 374–382. Available at: https://doi.org/10.1111/cen.13907.

Hepprich, Matthias et al. (2019) ‘Hypothyroidism manifesting as multiple cranial neuropathies: a case report’, Journal of medical case reports, 13(1), p. 180. Available at: https://doi.org/10.1186/s13256-019-2124-6.

Hepprich, M. et al. (2019) ‘Postprandial Hypoglycemia in Patients after Bariatric Surgery is Mediated by Glucose-Induced Il-1β’, SSRN Electronic Journal [Preprint]. Available at: https://doi.org/10.2139/ssrn.3455476.

Meienberg, Fabian et al. (2019) ‘The effect of exercise on intramyocellular acetylcarnitine (AcCtn) concentration in adult growth hormone deficiency (GHD)’, Scientific Reports, 9(1), p. 19431. Available at: https://doi.org/10.1038/s41598-019-55942-w.